Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-2-22
pubmed:abstractText
Carcinogens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 1,2-dimethylhydrazine (DMH) induce colon tumors in the rat that contain mutations in beta-catenin, but the pattern of mutation differs from that found in human colon cancers. In both species, mutations affect the glycogen synthase kinase-3beta consensus region of beta-catenin, but whereas they directly substitute critical Ser/Thr phosphorylation sites in human colon cancers, the majority of mutations cluster around Ser33 in the rat tumors. Two dietary phytochemicals, chlorophyllin and indole-3-carbinol, given post-initiation, shifted the pattern of beta-catenin mutations in rat colon tumors induced by IQ and DMH. Specifically, 17/39 (44%) of the beta-catenin mutations in groups given carcinogen plus modulator were in codons 37, 41 and 45, and substituted critical Ser/Thr residues directly, as seen in human colon cancers. None of the tumors from groups given carcinogen alone had mutations in these codons. Interestingly, many of the mutations that substituted critical Ser/Thr residues in beta-catenin were from a single group given DMH and 0.001% chlorophyllin, in which a statistically significant increase in colon tumor multiplicity was observed compared with the group given DMH only. These tumors had marked over-expression of cyclin D1, c-myc and c-jun mRNA and c-Myc and c-Jun proteins were strongly elevated compared with tumors containing wild-type beta-catenin. The results indicate that the pattern of beta-catenin mutations in rat colon tumors can be influenced by exposure to dietary phytochemicals administered post-initiation, and that the mechanism might involve the altered expression of beta-catenin/Tcf/Lef target genes.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1,2-Dimethylhydrazine, http://linkedlifedata.com/resource/pubmed/chemical/2-amino-3-methylimidazo(4,5-f)quinol..., http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens, http://linkedlifedata.com/resource/pubmed/chemical/Catnb protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Chlorophyllides, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/Cytoskeletal Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthine..., http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-jun, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators, http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin, http://linkedlifedata.com/resource/pubmed/chemical/chlorophyllin, http://linkedlifedata.com/resource/pubmed/chemical/indole-3-carbinol
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0143-3334
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
315-20
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11181454-1,2-Dimethylhydrazine, pubmed-meshheading:11181454-Animals, pubmed-meshheading:11181454-Anticarcinogenic Agents, pubmed-meshheading:11181454-Carcinogens, pubmed-meshheading:11181454-Chlorophyllides, pubmed-meshheading:11181454-Colonic Neoplasms, pubmed-meshheading:11181454-Cyclin D1, pubmed-meshheading:11181454-Cytoskeletal Proteins, pubmed-meshheading:11181454-DNA Mutational Analysis, pubmed-meshheading:11181454-Hypoxanthine Phosphoribosyltransferase, pubmed-meshheading:11181454-Indoles, pubmed-meshheading:11181454-Male, pubmed-meshheading:11181454-Mutation, pubmed-meshheading:11181454-Polymorphism, Single-Stranded Conformational, pubmed-meshheading:11181454-Proto-Oncogene Proteins c-jun, pubmed-meshheading:11181454-Proto-Oncogene Proteins c-myc, pubmed-meshheading:11181454-Quinolines, pubmed-meshheading:11181454-Rats, pubmed-meshheading:11181454-Rats, Inbred F344, pubmed-meshheading:11181454-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:11181454-Trans-Activators, pubmed-meshheading:11181454-beta Catenin
pubmed:year
2001
pubmed:articleTitle
beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.
pubmed:affiliation
Linus Pauling Institute and Department of Environment and Molecular Toxicology, Oregon State University, Corvallis, OR 97331-6512, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.